丛枝菌根真菌诱导玉米根系形态变化及其机理

以高油115和正大619为实验材料,分别通过盆栽和田间试验研究接种摩西球囊霉和地表球囊霉对玉米根系形态和根系内源生长素含量的影响。结果表明,玉米形成菌根后根系形态明显改变,根条数显著多于对照,并且接种处理与对照间的差异随菌根侵染率的上升而加大,差异极显著。生长60 d时,有菌根的玉米单株总根长度为788.61 cm,根系重量达8.26 g,均显著高于无菌根的对照。根系生长素含量随菌根侵染率上升而增加,并且显著高于不接种的对照。丛枝菌根真菌侵染可以促使玉米根内生长素含量上升,根条数增多,增加吸收面积,促进玉米生长。     

陕西杨陵地区猪弓形虫病的血清学调查研究

应用间接血凝试验（ＩＨＡ）对采自杨陵区食品公司屠宰点、西北农业大学实验农场种猪场,西北农林科技大学兽医院的２１４份猪血样进行弓形虫抗体的定性检测,包括血清检测法（１７６份）,滤纸干血滴法（３８份）两种方法。结果检出阳性血样５份,阳性率为２．３４％。其中来自杨陵区食品公司屠宰点猪血样１３６份,全部用血清检测法测定结果,阳性５份,阳性率为３．６８％,来自西北农林科技大学农场种猪场血样７６份,３８份血清     

黄芪注射液对犬心脏双向变时作用的初步观察

为了观察黄芪注射液对正常犬和二尖瓣关闭不全病理模型 (MR)犬的变时作用 ,并探讨其机制 ,在异氟烷吸入麻醉下 ,对正常及外科方法制作的犬亚急性二尖瓣关闭不全模型 (术后 5 0天后 )一次性静脉推注含生药 2 g/ m L的黄芪注射液 1 .2 5 m L/ kg,通过体表心电图测定心率和 PQ、QRS、RR、QT,并计算 QTC(QT/ RR)间期。在正常犬 ,开始注射黄芪注射液后 ,心率出现先减少后恢复再持续减少和显著变化。 MR模型犬开始注射液后 ,心率出现先升高后恢复再持续升高的显著变化。 MR模型犬的心率减慢变化与 RR、PQ、QT、QTc呈高度显著负相关 (P<0 .0 1 )。表明黄芪注射液对正常比格犬 ,具有加快心率的正性变时作用。对二尖瓣闭锁不全 (MR)模型犬具有减缓心率的负性变时作用。黄芪注射液的变时作用似与机体的机能状态有关 ,呈现双向调节作用。     

棘孢木霉(Trichoderma asperellum)固态发酵产纤维素酶及酶的性质

<正>纤维素酶具有破坏植物细胞壁,促进营养物质的消化和吸收,消除抗营养因子,提高饲料营养价值等多种功能,因而成为饲料工业研究的热点。目前用于纤维素酶生产和研究的菌株多为霉菌。棘孢木霉是我国新记录的木霉种[1],目前国内尚未见该菌种产纤维素酶的文献报道。     

利用家畜粪便有氧发酵生产有机肥的研究

畜禽场粪便污染已日益严重,如何利用这些废弃物资源已成为当务之急.本研究以牛粪和鸡粪为主要原料,经过接种EM活性菌在有氧条件下发酵腐熟,以缩短发酵时间为目的,分别对原料的含水量、原料翻堆次数进行了测定,结果表明:原料含水量在60%～65%,翻堆时间以45min/次为宜.发酵的腐熟度指标变化:(1)原料体积和重量减少1/3～1/2;(2)质感松软,颜色为暗棕黑色,无不良气味;(3)微细颗粒小于0.25mm,符合有机肥生产标准;(4)发酵自然温度稳定下降.     

免疫抑制对苏拉灭和贝尼尔治疗小鼠伊氏锥虫病疗效的影响

用从自然感染宿主分离的伊氏锥虫原种ＪＧ的克隆ＪＧｍｃ１和ＪＧｍｃ５感染免疫活性正常小鼠和免疫抑制小鼠，２４ｈ后，以苏拉灭或贝尼尔治疗，两种药物对免疫抑制小鼠的ＣＤ１００均明显高于免疫活性正常小鼠，由经受一次苏拉灭或贝尼尔治疗未愈的免疫抑制小鼠分离的锥虫，感染免疫活性正常小鼠，再用原来对该克隆感染的免疫活性正常小鼠ＣＤ１００的苏拉灭或贝尼尔治疗即无效。用免疫溶解试验分别测定一组免疫抑制和免疫活性正确     

Spatiotemporal heterogeneity of PPARγ expression in porcine uteroplacenta for regulating of placental angiogenesis through VEGF-mediated signalling

Non-infectious prenatal mortality severely affects the porcine industry, with pathological placentation as a likely key reason. Previous studies have demonstrated that peroxisome proliferator-activated receptor gamma (PPARγ) deficiency causes defects in the uteroplacental vasculature and induces embryonic losses in mice. However, its role in porcine placental angiogenesis remains unclear. In the present study, PPARγ expression was investigated in porcine uteroplacental tissues at gestational day (GD) 25, GD40 and GD70 via quantitative polymerase chain reaction (qPCR), Western blot and immunohistochemistry (IHC). Moreover, the roles of PPARγ in porcine placental angiogenesis were investigated using a cell model of porcine umbilical vein endothelial cells (PUVECs) to conduct proliferation, migration and tube formation assays in vitro and a mouse xenograft model to assess capillary formation in vivo. The results showed that PPARγ was mainly located in the glandular epithelium, trophoblast, amniotic chorion epithelium and vascular endothelium, as indicated by the higher expression levels at GD25 and GD40 than at GD70 in endometrium and by higher expression levels at GD40 and GD70 than at GD25 in placenta. Moreover, PPARγ expression was significantly downregulated in placenta with dead foetus. In PUVECs, knocking out PPARγ significantly inhibited proliferation, migration and tube formation in vitro and inhibited capillary formation in mouse xenografts in vivo by blocking S-phase, promoting apoptosis and downregulating the angiogenic factors of VEGF and its receptors. Overall, the spatiotemporal heterogeneity of PPARγ expression in porcine uteroplacental tissue suggests its vital role in endometrial remodelling and placental angiogenesis, and PPARγ regulates placental angiogenesis through VEGF-mediated signalling.     

Pharmacokinetics and bioavailability of valnemulin in broiler chickens

Wang, R., Yuan, L.G., He, L.M., Zhu, L.X., Luo, X.Y., Zhang, C.Y., Yu, J.J., Fang, B.H., Liu, Y.H. Pharmacokinetics and bioavailability of valnemulin in broiler chickens. J. vet. Pharmacol. Therap. 34 , 247–251. The objective of this study was to investigate the pharmacokinetics and bioavailability of valnemulin in broiler chickens after intravenous (i.v.), intramuscular (i.m.) and oral administrations of 10 mg/kg body weight (bw). Plasma samples were analyzed by high‐performance liquid chromatography–tandem mass spectrometry (HPLC‐MS/MS). Pharmacokinetic characterization was performed by non‐compartmental analysis using WinNonlin program. After intravenous administration, distribution was wide with the volume of distribution based on terminal phase(V_z) of 4.27 ± 0.99 L /kg. Mean valnemulin t_1/2β(h), Cl_β(L /h /kg), V_ss (L /kg) and AUC_(0–∞)(μg·h /mL) values were 2.85, 0.99, 2.72 and 10.34, respectively. After intramuscular administration, valnemulin was rapidly absorbed with a C_max of 2.2 μg/mL achieved at 0.43 h (t_max), and the absolute bioavailability (F) was 88.81%; and for the oral route the same parameters were 0.66 ± 0.15 μg/mL, 1.54 ± 0.27 h and 74.42%. A multiple‐peak phenomenon was present after oral administration. The plasma profile of valnemulin exhibited a secondary peak during 2–6 h and a tertiary peak at 32 h. The favorable PK behavior, such as the wide distribution, slow elimination and acceptable bioavailability indicated that it is likely to be effective in chickens.